Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.8K Sell
426
-235
-36% -$5.19K ﹤0.01% 2307
2026
Q1
$9.66K Buy
661
+32
+5% +$470 ﹤0.01% 2275
2025
Q4
$7.95K Sell
629
-2,137
-77% -$31.5K ﹤0.01% 2246
2025
Q3
$42.5K Buy
2,766
+1,644
+147% +$26.5K ﹤0.01% 1230
2025
Q2
$17.6K Sell
1,122
-592
-35% -$8.97K ﹤0.01% 1545
2025
Q1
$32.7K Buy
1,714
+1,632
+1,990% +$35.7K ﹤0.01% 1179
2024
Q4
$1.96K Buy
82
+67
+447% +$1.87K ﹤0.01% 1893
2024
Q3
$420 Hold
15
﹤0.01% 2168
2024
Q2
$392 Buy
+15
New +$312 ﹤0.01% 1899
2023
Q1
Sell
-281
Closed -$4.83K 1598
2022
Q4
$4.83K Buy
+281
New +$4.99K ﹤0.01% 1037

Other funds holding RXO

Larson Financial Group's RXO Position: Q2 2026 in Review

Larson Financial Group reduced its RXO (RXO) stake by 36% in Q2 2026, selling an estimated $5.19K and leaving 426 shares worth $11.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2307.

Larson Financial Group first reported a position in RXO in Q4 2022 and has held it in 10 quarters since. The position peaked at $42.5K in Q3 2025. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Larson Financial Group held 426 shares of RXO worth $11.8K as of Q2 2026.
  • Larson Financial Group sold 235 RXO shares in Q2 2026, an estimated $5.19K.
  • RXO made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2307 holding.
  • Larson Financial Group first reported a position in RXO in Q4 2022 and has held it in 10 quarters since.
  • Larson Financial Group's RXO position peaked at $42.5K in Q3 2025.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.